NCT02141113 - Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65). | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

November 30, 2014

Conditions

Adult Attention-Deficit Hyperactivity Disorder

Interventions

DRUG

Guanfacine Hydrochloride

"1. mg Guanfacine Hydrochloride (orally)~2. mg Guanfacine Hydrochloride (orally)~3. mg Guanfacine Hydrochloride (orally)~4. mg Guanfacine Hydrochloride (orally)~5. mg Guanfacine Hydrochloride (orally)~6. mg Guanfacine Hydrochloride (orally)"

OTHER

Placebo

Placebo of matching mg

Trial Locations (1)

48307

Rochester Center for Behavioral Medicine, Rochester Hills